12:00 AM
Apr 10, 2000
 |  BC Week In Review  |  Clinical News  |  Clinical Results

IPL576: Phase I

IZP said that its 99-patient U.K. Phase I trial, in which 73 subjects received either single or multiple doses of IPL576,092 for...

Read the full 88 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >